510 related articles for article (PubMed ID: 17405794)
1. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
3. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
4. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
5. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
6. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
[TBL] [Abstract][Full Text] [Related]
7. Incidence of peritonitis, distribution of causative bacteria and outcome in continuous ambulatory peritoneal dialysis (CAPD) in Kuwait.
al-Hilali N; Cozma G; Abu Romeh S; Van der Meulen J; Johny KV
APMIS Suppl; 1988; 3():101-3. PubMed ID: 3179071
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.
Pajek J; Kveder R; Bren A; Gucek A; Bucar M; Skoberne A; Waniewski J; Lindholm B
Nephrol Dial Transplant; 2009 May; 24(5):1617-25. PubMed ID: 19066345
[TBL] [Abstract][Full Text] [Related]
9. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
[TBL] [Abstract][Full Text] [Related]
11. In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.
Mackenzie RK; Jones S; Moseley A; Holmes CJ; Argyle R; Williams JD; Coles GA; Pu K; Faict D; Topley N
Am J Kidney Dis; 2000 Jan; 35(1):112-21. PubMed ID: 10620552
[TBL] [Abstract][Full Text] [Related]
12. 'O' set connector system in CAPD.
Annigeri RA; Prakash GK; Balasubramaniyam R; Balasubramaniam S; Prakash KC; Kavitha MK
J Assoc Physicians India; 1996 Sep; 44(9):602-5. PubMed ID: 9251369
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
14. The influence of seasonal factors on the incidence of peritonitis in continuous ambulatory peritoneal dialysis in the temperate zone.
Kim MJ; Song JH; Park YJ; Kim GA; Lee SW
Adv Perit Dial; 2000; 16():243-7. PubMed ID: 11045303
[TBL] [Abstract][Full Text] [Related]
15. Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients. An analysis of data from the French Language Peritoneal Dialysis Registry.
Verger C; Duman M; Durand PY; Veniez G; Fabre E; Ryckelynck JP
Nephrol Dial Transplant; 2007 Apr; 22(4):1218-23. PubMed ID: 17267540
[TBL] [Abstract][Full Text] [Related]
16. Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients.
Locatelli AJ; Marcos GM; Gómez MG; Alvarez SA; DeBenedetti LC
Adv Perit Dial; 1999; 15():193-6. PubMed ID: 10682100
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).
Kavanagh D; Prescott GJ; Mactier RA
Nephrol Dial Transplant; 2004 Oct; 19(10):2584-91. PubMed ID: 15304559
[TBL] [Abstract][Full Text] [Related]
18. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
19. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
[TBL] [Abstract][Full Text] [Related]
20. Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
Benjamin J; Ben-Ezer Gradus D; Mostoslavski M; Rapoport J; Chaimovitz C
Isr J Med Sci; 1989 Dec; 25(12):699-702. PubMed ID: 2613500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
